Cornerstone Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,300
Closed -$175K 212
2025
Q3
$175K Buy
+11,300
New +$155K 0.01% 227
2024
Q3
Sell
-22,339
Closed -$317K 299
2024
Q2
$317K Sell
22,339
-9,575
-30% -$129K 0.01% 283
2024
Q1
$435K Sell
31,914
-462,426
-94% -$6.4M 0.02% 293
2023
Q4
$6.65M Buy
494,340
+209,708
+74% +$2.58M 0.29% 86
2023
Q3
$3.55M Buy
284,632
+27,333
+11% +$359K 0.17% 149
2023
Q2
$3.48M Buy
257,299
+5,109
+2% +$70.5K 0.17% 144
2023
Q1
$3.51M Buy
252,190
+1,700
+0.7% +$24.3K 0.16% 123
2022
Q4
$3.56M Buy
250,490
+72,000
+40% +$1.04M 0.18% 126
2022
Q3
$2.44M Buy
178,490
+164,990
+1,222% +$2.47M 0.12% 151
2022
Q2
$192K Buy
+13,500
New +$204K 0.01% 188
2020
Q1
Sell
-175,073
Closed -$3.05M 194
2019
Q4
$3.05M Buy
+175,073
New +$2.87M 0.25% 107
2019
Q1
$360K Buy
21,000
+5,000
+31% +$86.3K 0.03% 183
2018
Q4
$242K Buy
+16,000
New +$282K 0.02% 218

Other funds holding HQL

Cornerstone Advisors's HQL Position: Q4 2025 in Review

Cornerstone Advisors sold out of abrdn Life Sciences Investors (HQL) in Q4 2025, closing a stake of 11,300 shares — an estimated $175K sold.

Cornerstone Advisors first reported a position in HQL in Q4 2018 and held it in 13 quarters. The position peaked at $6.65M in Q4 2023. 73 funds tracked by Wall St. Rank hold HQL as of Q4 2025.

  • Cornerstone Advisors reported no remaining abrdn Life Sciences Investors position as of Q4 2025 after selling out during the quarter.
  • Cornerstone Advisors sold 11,300 abrdn Life Sciences Investors shares in Q4 2025, an estimated $175K.
  • Cornerstone Advisors first reported a position in abrdn Life Sciences Investors in Q4 2018 and held it in 13 quarters.
  • Cornerstone Advisors's abrdn Life Sciences Investors position peaked at $6.65M in Q4 2023.
  • 73 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2025.

Based on Cornerstone Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.